Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
FUROSEMIDA FRESENIUS KABI 20 MG/2 ML SOLUCION INYECTABLE Y PARA PERFUSION EFG
Injection
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- FUROSEMIDA — 10 mg
- Pharmaceutical form Home Med Cabinet grouping
- Injection
- Availability in Spain
- 1 of 2 packs marketed
Packs
FUROSEMIDA FRESENIUS KABI 20 MG/2 ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 50 ampollas de 2 ml
50 ampoules
National code
Marketed602712Strength of this pack 20 mg
FUROSEMIDA FRESENIUS KABI 20 MG/2 ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 100 ampollas de 2 ml
100 ampoules
National code
Not marketed602713Strength of this pack 20 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 69097Official data
- Marketing authorisation holder
- FRESENIUS KABI ESPAÑA, S.A.U.Official data
- Authorised
- Jul 12, 2007Official data
- Authority form code
- 197Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.